Apimeds Pharmaceuticals Us, INC. (APUS) — S-1/A Filings

All S-1/A filings from Apimeds Pharmaceuticals Us, INC.. Browse 7 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (7)

Apimeds Pharmaceuticals Files S-1/A Amendment — Feb 10, 2025 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on February 10, 2025, for its registration statement (No. 333-282324). The company, incorporated in De
Apimeds Pharmaceuticals Files S-1/A Amendment — Feb 6, 2025 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on February 6, 2025, for its registration statement. The company, incorporated in Delaware, is based i
Apimeds Pharmaceuticals Files S-1/A Amendment — Jan 29, 2025 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on January 29, 2025, for its registration statement (No. 333-282324). The company, incorporated in Del
Apimeds Pharmaceuticals Files S-1/A Amendment — Jan 10, 2025 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on January 10, 2025, for its registration statement. The company, incorporated in Delaware, is in the
Apimeds Pharmaceuticals Files S-1/A Amendment — Dec 20, 2024 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on December 20, 2024, for its registration statement (No. 333-282324). The company, incorporated in De
Apimeds Pharmaceuticals Files IPO Amendment — Dec 9, 2024 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on December 9, 2024, for its initial public offering. The company, incorporated in Delaware, is seekin
Apimeds Pharmaceuticals Files S-1/A Amendment — Nov 8, 2024 Risk: medium
Apimeds Pharmaceuticals US, Inc. filed an S-1/A amendment on November 8, 2024, for its registration statement. The company, incorporated in Delaware, is in the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX